Detection and Frequency of HBV Profile in Chronic HBV Positive Patients in District Mardan, Khyber Pakhtunkhwa
DOI:
https://doi.org/10.47957/ijciar.v8i2.200Keywords:
Hepatitis B virus (HBV), Serological markers, Prevalence, Risk factors, Public health interventionsAbstract
Background: Hepatitis B Virus (HBV) infection is a significant health issue in most parts of the world especially those low-resource settings such as rural Pakistan. Complications of chronic HBV may be serious, as these lead to cirrhosis and hepatocellular carcinoma. The current study considered an evaluation of HBV serological marker prevalence and risk factors of chronic HBV-positive individuals in District Mardan, Khyber Pakhtunkhwa, Pakistan.
Purposes: The aim was to identify the rate of the HBV markers (HBsAg, HBeAg, HBcAg, HBsAb, HBeAb, and HBcAb) and assess vaccination status, access to treatment, and advanced education on the topic of HBV in the patients with the infection.
Methodology: It was a cross-sectional study with 50 samples of HBV positive blood selected in District Mardan. The serological markers were detected with the help of Immunochromatographic Technique (ICT). The processing of data was performed based on SPSS 23.0 and Microsoft Excel and concentrated on demographic allocation, risk factors, and healthcare gaps.
Results: All samples preserved positive results in HBsAg (100 percent) indicating an active infection. Additional markers were also found at a different rate: HBeAg (18%), HBcAg (6%), HBsAb (42%), HBeAb (14%) and HBcAb (4%). Among the primary results were low rates of vaccination (8%), access to treatment (78%), and health education (86%). There were unsafe medical practices and familial transmission as some of the risk factors.
Conclusion: The analysis report singles out the high burden of HBV infection in District Mardan, and a high gap in the prevention and treatment. Emerging Control Measures to curb the spread of HBV and the resulting effects to the community, untimely control measures should be adopted like enhanced vaccination, enhanced diagnostic capacity and community health education.
Downloads
References
Caballero A, Tabernero D, Buti M, Rodriguez-Frias F. Hepatitis B virus: The challenge of an ancient virus with multiple faces and a remarkable replication strategy. Antiviral research. 2018 Oct 1;158:34-44. DOI: https://doi.org/10.1016/j.antiviral.2018.07.019
Lim JK, Nguyen MH, Kim WR, Gish R, Perumalswami P, Jacobson IM. Prevalence of chronic hepatitis B virus infection in the United States. Official journal of the American College of Gastroenterology| ACG. 2020;115(9):1429-38. DOI: https://doi.org/10.14309/ajg.0000000000000651
MUHAMMAD T, AHMAD H, ULLAH H. Sero-prevalence and Associated Complications of Hepatitis B Virus Infected Patients of Khyber Pakhtunkhwa (2021).
Awan ZU, Shah AH, Khan S. Molecular characterization of hepatitis B virus (HBV) genotypes in HBsAg positive individuals of Khyber Pakhtunkhwa, Pakistan. African Journal of Microbiology Research. 2012 Jun 28;6(24):5237-42.
Gohar M, REHMAN I, Ahmad J, Ahmad F, Bashir K, Ikram S, et al. Prevalence of hepatitis b virus and genotypes in the region of khyber pakhtunkhwa Pakistan. Bulletin of Biological and Allied Sciences Research. 2023;2023(1):53-. DOI: https://doi.org/10.54112/bbasr.v2023i1.53
Aziz S, Akbar A, Iqbal S, Tawab F, Inayat N. Prevalence of HBV Infection and Associated Risk Factors in the General Population of District Peshawar, Pakistan. Indus Journal of Bioscience Research. 2024;2(02):418-23. DOI: https://doi.org/10.70749/ijbr.v2i02.170
Bosan A, Qureshi H, Bile KM, Ahmad I, Hafiz R. A review of hepatitis viral infections in Pakistan. JPMA-Journal of the Pakistan Medical Association. 2010;60(12):1045.
Pattyn J, Hendrickx G, Vorsters A, Van Damme P. Hepatitis B vaccines. The Journal of infectious diseases. 2021;224(Supplement_4):S343-S51. DOI: https://doi.org/10.1093/infdis/jiaa668
Hwang EW, Cheung R. Global epidemiology of hepatitis B virus (HBV) infection. North American Journal of Medicine and Science. 2011;4(1). DOI: https://doi.org/10.7156/v4i1p007
Mehmood S, Raza H, Abid F, Saeed N, Rehman HM, Javed S, et al. National prevalence rate of hepatitis B and C in Pakistan and its risk factors. Journal of Public Health. 2020;28:751-64. DOI: https://doi.org/10.1007/s10389-019-01081-5
Rizzo GEM, Cabibbo G, Craxì A. Hepatitis B virus-associated hepatocellular carcinoma. Viruses. 2022;14(5):986. DOI: https://doi.org/10.3390/v14050986
Kumar M, Pahuja S, Khare P, Kumar A. Current challenges and future perspectives of diagnosis of hepatitis B virus. Diagnostics. 2023;13(3):368. DOI: https://doi.org/10.3390/diagnostics13030368
Kuhns MC, Holzmayer V, Anderson M, McNamara AL, Sauleda S, Mbanya D, et al. Molecular and serological characterization of hepatitis B virus (HBV)-positive samples with very low or undetectable levels of HBV surface antigen. Viruses. 2021;13(10):2053. DOI: https://doi.org/10.3390/v13102053
Conners EE. Screening and testing for hepatitis B virus infection: CDC recommendations—United States, 2023. MMWR Recommendations and Reports. 2023;72. DOI: https://doi.org/10.15585/mmwr.rr7201a1
Thakur V, Guptan RC, Kazim SN, Malhotra V, Sarin SK. Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. Journal of gastroenterology and hepatology. 2002;17(2):165-70. DOI: https://doi.org/10.1046/j.1440-1746.2002.02605.x
Hsu Y-C, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nature reviews Gastroenterology & hepatology. 2023;20(8):524-37. DOI: https://doi.org/10.1038/s41575-023-00760-9
Published
How to Cite
Issue
Section
Citations
Copyright (c) 2025 Rasheed Ahmad, Hamad Ali, Sadeeq Bacha, Subhan Ullah, Saeed Ullah, Qaisar Ali
This work is licensed under a Creative Commons Attribution 4.0 International License.
